FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Anna Bonjoch

Research Profile

Disorders

HIV Infections

Living Beings

HIV-1

Chemicals & Drugs

Concepts & Ideas

Procedures

Activities & Behaviors

Patient Compliance

Physiology

Viral Drug Resistance

Co-author Network

Publications

TOP 3
Anna Bonjoch; Bonaventura Clotet; Patricia Echeverría; Carla Estany; Núria Perez-Alvarez; Jordi Puig; Eugenia Negredo
High rate of reversibility of renal damage in a cohort of HIV-infected patients receiving tenofovir-containing antiretroviral therapy.
Eugenia Negredo; Nuria Perez-Alvarez; Jordi Puig; Joaquin Rosales; Luís del Rio; Silvana di Gregorio; Carla Estany; Guadalupe Gómez; Moisés Gómez-Mateu; Anna Bonjoch; Bonaventura Clotet
Time of progression to osteopenia/osteoporosis in chronically HIV-infected patients: screening DXA scan.
Maria José Buzón; Bonaventura Clotet; Eoin Coakley; Francisco M Codoñer; Judith Dalmau; Pham Phung; Terri Wrin; Anna Bonjoch; Javier Martinez-Picado
Combined antiretroviral therapy and immune pressure lead to in vivo HIV-1 recombination with ancestral viral genomes.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Anna Bonjoch (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Anna Bonjoch; Bonaventura Clotet; Patricia Echeverría; Carla Estany; Núria Perez-Alvarez; Jordi Puig; Eugenia Negredo
High rate of reversibility of renal damage in a cohort of HIV-infected patients receiving tenofovir-containing antiretroviral therapy.
Antiviral research 2012;96(1):65-9.
2012: Eugenia Negredo; Nuria Perez-Alvarez; Jordi Puig; Joaquin Rosales; Luís del Rio; Silvana di Gregorio; Carla Estany; Guadalupe Gómez; Moisés Gómez-Mateu; Anna Bonjoch; Bonaventura Clotet
Time of progression to osteopenia/osteoporosis in chronically HIV-infected patients: screening DXA scan.
PloS one 2012;7(10):e46031.
2011: Maria José Buzón; Bonaventura Clotet; Eoin Coakley; Francisco M Codoñer; Judith Dalmau; Pham Phung; Terri Wrin; Anna Bonjoch; Javier Martinez-Picado
Combined antiretroviral therapy and immune pressure lead to in vivo HIV-1 recombination with ancestral viral genomes.
Journal of acquired immune deficiency syndromes (1999) 2011;57(2):109-17.
2006: Eugenia Negredo; José Moltó; Jordi Puig; Denise Cinquegrana; Anna Bonjoch; Núria Pérez-Alvarez; Raquel López-Blázquez; Asunción Blanco; Bonaventura Clotet; Celestino Rey-Joly
Ezetimibe, a promising lipid-lowering agent for the treatment of dyslipidaemia in HIV-infected patients with poor response to statins.
AIDS (London, England) 2006;20(17):2159-64.
2006: Cecilia Cabrera; Silvia Marfil; Elisabet García; Javier Martinez-Picado; Anna Bonjoch; Margarita Bofill; Santiago Moreno; Esteban Ribera; Pere Domingo; Bonaventura Clotet; Lidia Ruiz
Genetic evolution of gp41 reveals a highly exclusive relationship between codons 36, 38 and 43 in gp41 under long-term enfuvirtide-containing salvage regimen.
AIDS (London, England) 2006;20(16):2075-80.
2006: Anna Bonjoch; Eugenia Negredo; Jordi Puig; Itziar Erkizia; Teresa Puig; Cecilia Cabrera; Lidia Ruiz; Bonaventura Clotet
Viral failure in HIV-infected patients with long-lasting viral suppression who discontinued enfuvirtide.
AIDS (London, England) 2006;20(14):1896-8.
2006: Eugenia Negredo; Anna Bonjoch; Bonaventura Clotet
Benefits and concerns of simplification strategies in HIV-infected patients.
The Journal of antimicrobial chemotherapy 2006;58(2):235-42.
2006: Anna Bonjoch; Roger Paredes; Pere Domingo; Manel Cervantes; Enric Pedrol; Esteban Ribera; Lluís Force; Josep M Llibre; Josep Vilaró; David Dalmau; Josep Cucurull; Jaume Mascaró; Angels Masabeu; Núria Pérez-Alvarez; Jordi Puig; Denise Cinquegrana; Bonaventura Clotet
Long-term safety and efficacy of nevirapine-based approaches in HIV type 1-infected patients.
AIDS research and human retroviruses 2006;22(4):321-9.
2006: José Moltó; Lidia Ruiz; Marta Valle; Javier Martinez-Picado; Anna Bonjoch; Isabel Bravo; Eugenia Negredo; Gabrielle M Heilek-Sneider; Bonaventura Clotet
Increased antiretroviral potency by the addition of enfuvirtide to a four-drug regimen in antiretroviral-naive, HIV-infected patients.
Antiviral therapy 2006;11(1):47-51.
2005: Eugenia Negredo; Anna Bonjoch; Roger Paredes; Jordi Puig; Bonaventura Clotet
Compromised immunologic recovery in treatment-experienced patients with HIV infection receiving both tenofovir disoproxil fumarate and didanosine in the TORO studies.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2005;41(6):901-5.
2005: Anna Bonjoch; Roger Paredes; Juan Galvez; Celia Miralles; Sebastián Videla; Eva Martínez; Jose Miranda; Jose Munoz-Moreno; Javier de la Torre; Arturo Prieto; Consuelo Vilades; Bonaventura Clotet
Antiretroviral treatment simplification with 3 NRTIs or 2 NRTIs plus nevirapine in HIV-1-infected patients treated with successful first-line HAART.
Journal of acquired immune deficiency syndromes (1999) 2005;39(3):313-6.
2003: Lidia Ruiz; Esteban Ribera; Anna Bonjoch; Joan Romeu; Javier Martinez-Picado; Roger Paredes; Marjorie Díaz; Silvia Marfil; Eugenia Negredo; Julia García-Prado; Cristina Tural; Guillem Sirera; Bonaventura Clotet
Role of structured treatment interruption before a 5-drug salvage antiretroviral regimen: the Retrogene Study.
The Journal of infectious diseases 2003;188(7):977-85.
2002: Carmina R Fumaz; Albert Tuldrà; Maria José Ferrer; Roger Paredes; Anna Bonjoch; Toni Jou; Eugenia Negredo; Joan Romeu; Guillem Sirera; Cristina Tural; Bonaventura Clotet
Quality of life, emotional status, and adherence of HIV-1-infected patients treated with efavirenz versus protease inhibitor-containing regimens.
Journal of acquired immune deficiency syndromes (1999) 2002;29(3):244-53.
2002: Eugenia Negredo; Luís Cruz; Roger Paredes; Lidia Ruiz; Carmina R Fumaz; Anna Bonjoch; Silvia Gel; Albert Tuldrà; Montserrat Balagué; Susan Johnston; Albert Arno; Antoni Jou; Cristina Tural; Guillem Sirera; Joan Romeu; Bonaventura Clotet
Virological, immunological, and clinical impact of switching from protease inhibitors to nevirapine or to efavirenz in patients with human immunodeficiency virus infection and long-lasting viral suppression.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2002;34(4):504-10.
2001: Lidia Ruiz; Eugenia Negredo; Pere Domingo; Roger Paredes; E Francia; Montserrat Balagué; Silvia Gel; Anna Bonjoch; Carmina R Fumaz; Susan Johnston; Joan Romeu; J Lange; Bonaventura Clotet
Antiretroviral treatment simplification with nevirapine in protease inhibitor-experienced patients with hiv-associated lipodystrophy: 1-year prospective follow-up of a multicenter, randomized, controlled study.
Journal of acquired immune deficiency syndromes (1999) 2001;27(3):229-36.
2000: Albert Tuldrà; Carmina R Fumaz; Maria José Ferrer; Ramon Bayés; Albert Arno; Montserrat Balagué; Anna Bonjoch; Antoni Jou; Eugenia Negredo; Roger Paredes; Lidia Ruiz; Joan Romeu; Guillem Sirera; Cristina Tural; David Burger; Bonaventura Clotet
Prospective randomized two-Arm controlled study to determine the efficacy of a specific intervention to improve long-term adherence to highly active antiretroviral therapy.
Journal of acquired immune deficiency syndromes (1999) 2000;25(3):221-8.
2000: José L Casado; Kurt Hertogs; Lidia Ruiz; Fernando Dronda; A Van Cauwenberge; Albert Arno; I Garcia-Arata; Stuart Bloor; Anna Bonjoch; J Blazquez; Bonaventura Clotet; Brendan Larder
Non-nucleoside reverse transcriptase inhibitor resistance among patients failing a nevirapine plus protease inhibitor-containing regimen.
AIDS (London, England) 2000;14(2):F1-7.
1999: Roger Paredes; Teresa Puig; Albert Arno; Eugenia Negredo; Montserrat Balagué; Anna Bonjoch; Antoni Jou; Albert Tuldrà; Cristina Tural; Guillem Sirera; A Veny; Joan Romeu; Lidia Ruiz; Bonaventura Clotet
High-dose saquinavir plus ritonavir: long-term efficacy in HIV-positive protease inhibitor-experienced patients and predictors of virologic response.
Journal of acquired immune deficiency syndromes (1999) 1999;22(2):132-8.
1999: Eugenia Negredo; Roger Paredes; Anna Bonjoch; Albert Tuldrà; Carmina R Fumaz; Silvia Gel; B Garcés; Susan Johnston; Albert Arno; Montserrat Balagué; Antoni Jou; Cristina Tural; Guillem Sirera; Joan Romeu; L Cruz; E Francia; Pere Domingo; Julio Arrizabalaga; I Ruiz; José R Arribas; Lidia Ruiz; Bonaventura Clotet
Benefit of switching from a protease inhibitor (PI) to nevirapine in PI-experienced patients suffering acquired HIV-related lipodystrophy syndrome (AHL): interim analysis at 3 months of follow-up.
Antiviral therapy 1999;4 Suppl 3():23-8.
1998: Lidia Ruiz; Monique Nijhuis; C Boucher; Teresa Puig; Anna Bonjoch; Javier Martínez-Picado; Silvia Marfil; D de Jong; David Burger; Albert Arno; Montserrat Balagué; Bonaventura Clotet
Efficacy of adding indinavir to previous reverse transcriptase nucleoside analogues in relation to genotypic and phenotypic resistance development in advanced HIV-1-infected patients.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1998;19(1):19-28.
1998: Cristina Tural; Joan Romeu; Guillem Sirera; D Andreu; M Conejero; S Ruiz; Antoni Jou; Anna Bonjoch; Lidia Ruiz; Albert Arno; Bonaventura Clotet
Long-lasting remission of cytomegalovirus retinitis without maintenance therapy in human immunodeficiency virus-infected patients.
The Journal of infectious diseases 1998;177(4):1080-3.